Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 3, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc.
| 8K |
—
|
—
| +50.61% | 23.81K |
May 30
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Surface Oncology, Inc.
| -45.45K |
—
|
—
| -100.00% |
0
|
Sep 8
| |||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
|
Jul 3
| |||||||
Vir Biotechnology, Inc.
| 6.03K |
—
|
—
| +61.63% | 15.81K |
May 22
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Vir Biotechnology, Inc.
| 2.5K |
$22.73 | $56,815.50 | +33.33% | 10K |
Mar 1
|
Scheduled
| ||||||
Vir Biotechnology, Inc.
| 2.5K |
$24.96 | $62,395.50 | +50.00% | 7.5K |
Jan 5
|
Scheduled
| ||||||
Vir Biotechnology, Inc.
| 5K |
$25.43 | $127,128.75 |
∞
| 5K |
Jan 3 - Jan 4
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 22
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Surface Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Vir Biotechnology, Inc.
| 6.41K |
—
|
—
| +189.83% | 9.78K |
May 23
| |||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Surface Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Vir Biotechnology, Inc.
| 3.37K |
—
|
—
|
∞
| 3.37K |
May 21
| |||||||
Vir Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 10
| |||||||
Vir Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 10
| |||||||
Vir Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Surface Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Surface Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 1
| |||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
|
Jul 2
| |||||||
Surface Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Surface Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 5
| |||||||
Surface Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 2
| |||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Surface Oncology, Inc.
| 45.45K |
—
|
—
|
∞
| 45.45K |
Apr 23
| |||||||
Surface Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
|
Jul 3
| |||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
|
Aug 11
| |||||||
Adaptimmune Therapeutics Plc
| 15K |
$1.56 | $23,400.00 | +5.02% | 314.1K |
May 19
| |||||||
Adaptimmune Therapeutics Plc
| 45K |
$1.53 | $68,700.00 | +17.71% | 299.1K |
May 16 - May 18
| |||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.